Nchi: Uswisi
Lugha: Kiitaliano
Chanzo: Swissmedic (Swiss Agency for Therapeutic Products)
rituximabum
Pfizer AG
L01XC02
rituximabum
Concentrato per soluzione per Infusione
rituximabum 500 mg, histidinum, histidini hydrochloridum monohydricum, dinatrii edetas corresp. natrium 0.35 mg, polysorbatum 80, saccharum, aqua ad iniectabilia q.s. ad solutionem pro 50 ml.
A
Biotechnologika
Non-Hodgkin-Lymphom, Rheumatoide Arthritis, ANCA-assoziierte Vaskulitis (AAV)
2020-08-04